BMN 673 Talazoparib also known as MDV-3800, is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
魯卡帕尼 Rucaparib Rucaparib is a tricyclic indole poly(ADP-Ribose) polymerase (PARP1) inhibitor with potential chemosensitizing, radiosensitizing, and antineoplastic activities.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
尼拉帕尼 Niraparib Niraparib, also known as MK4827, is an orally active, potent and selective poly(ADP-Ribose) polymerase (PARP) inhibitor that radiosensitizes human lung and breast cancer cells.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
奧拉帕尼 Olaparib Olaparib, also known as AZD-2281 or KU-59436 , is a small molecule inhibitor of the nuclear enzyme po奧拉帕利 Olaparibradiosensitizing,
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
拉羅替尼 Larotrectinib Larotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent, ATP-competitive inhibitor of TRKA, TRKB, and TRKC.
更新時(shí)間:2023-07-12
廠(chǎng)商性質(zhì):代理商
微信掃一掃